Key Takeaways:
1. Two guidelines, two definitions of hypertension: The 2017 ACC/AHA guideline defines stage 1 hypertension as a BP of 130/80 mmHg or above. In contrast, the hypertension guideline from the 8th Joint National Committee (JNC 8) defines hypertension as BP of 140/90 mmHg or above - an ongoing controversy.
2. Think preventive: ACC/AHA recommends lifestyle changes for patients with "elevated" BP and those with stage 1 hypertension who have a 10-year cardiovascular risk less than 10%.
3. First Line Treatments: Both JNC 8 and ACC/AHA recommend thiazide-type diuretics (TTDs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs) as first line drug options.
Hypertension is a leading cause of cardiovascular disease, stroke, heart failure, and kidney disease. According to a recent update from the CDC National Center for Health Statistics, nearly 30% of adults in the US have hypertension. The rate of hypertension is similar among women (28%) and men (30%). It is more common among US non-hispanic black adults than any other ethnicity. Within age groups, the incidence ranges from 7.5% among adults 18-39 years old to 63% in those age 60 and older. Of concern is that hypertension control has not been improving. In 2015-2016, only 48% of adults with hypertension had achieved control which, at the time, was considered blood pressure less than 140/90 mmHg.
Recently, the American College of Cardiology (ACC) and the American Heart Association (AHA) released an updated guideline for the prevention, detection, evaluation and management of hypertension.2 The 2017 ACC/AHA guideline was developed and approved in collaboration with 9 other professional groups, including the American Pharmacists Association (APhA). A multidisciplinary, team-based approach to hypertension management is strongly recommended (including the patient, primary provider, and other professionals such as cardiologists, nurses, physician assistants, pharmacists, and dietitians)...
Fee
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacy Technicians
Accreditation(s)
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
- The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
- Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.
- Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
Requirements for CE Credit
Objectives
- Name 4 drug classes recommended by current guidelines as first-line options for antihypertensive therapy. List the generic and brand names of at least 3 drugs of each class, and state their usual maintenance doses.
- For each of the recommended first-line drug classes, list common and serious side effects, drug interactions, contraindications, and precautions.
Speaker(s)/Author(s)
|
Kimberly M. Crosby, PharmD, BCPS, CDE, BC-ADM, BCGP
Brief Bio : Kimberly M. Crosby, PharmD, BCPS, CDE, BC-ADM, BCGP is an Associate Professor in the Family Medicine Department, College of Medicine, at the University of Oklahoma (OU) School of Community Medicine. She practices as a clinical pharmacist for the Tulsa Family Medicine Clinic and the OU Bedlam Clinics. |
Activity Number
0428-0000-18-005-H01-T